The Impact of Aprotinin on Renal Function After Liver Transplantation: An Analysis of 1043 Patients
β Scribed by N. Warnaar; S. V. Mallett; M. T. De Boer; N. Rolando; A. K. Burroughs; M. W. N. Nijsten; M. J. H. Slooff; K. Rolles; R. J. Porte
- Book ID
- 114804495
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 120 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Aprotinin is an antifibrinolytic drug that reduces blood loss during orthotopic liver transplantation (OLT). Case reports have suggested that aprotinin may be associated with an increased risk of thromboembolic complications. Recent studies in cardiac surgery also have suggested a higher risk of ren
Although renal dysfunction is common after liver transplantation, postoperative renal function after split liver transplantation (SLT) has not been well studied. Renal function immediately after surgery was analyzed retrospectively in 16 patients that received a SLT (SLT group). The results were com